Oxford Global Conferences, Hilton San Diego Bayfront
12-13 October
Day One: Biomarkers in Drug Discovery & Translational Sciences Biomarkers for Diagnostic Development Biomarkers for Clinical Development Day Two: New Biomarker Technologies & Data Genomic Markers in Precision Medicine & Clinical Practice
|
|
|
Invited Speakers:
|
|
Panna Sharma: President & Chief Executive Officer, Lantern Pharma Meena Subramanyam: Vice President, Global Program Leader & Portfolio Lead, Immune Cell Engagers Katie Newhall: Vice President, Translational Clinical Development, Cellectis Majid Ghoddusi, Executive Director, Clinical Biomarkers, Janux Therapeutics Matthias Von Herrath, Vice President & Senior Medical Officer, Novo Nordisk
|
|